FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4327894164> ?p ?o ?g. }

• W4327894164 endingPage "2127" @default.
• W4327894164 startingPage "2119" @default.
• W4327894164 abstract "Encapsulation into liposomes is a formulation strategy that can improve efficacy and reduce side effects of active pharmaceutical ingredients (APIs) that exhibit poor biodistribution or pharmacokinetics when administered alone. However, many APIs are unsuitable for liposomal formulations intended for parenteral administration due to their inherent physicochemical properties─lipid bilayer permeability and water-lipid equilibrium partitioning coefficient. Too high permeability results in premature leakage from liposomes, while too low permeability means the API is not able to pass across biological barriers. There are several options for solving this issue: (i) change of the lipid bilayer composition, (ii) addition of a permeability enhancer, or (iii) modification of the chemical structure of the API to design a prodrug. The latter approach was taken in the present work, and the effect of small changes in the molecular structure of the API on its permeation rate across a lipidic bilayer was systematically explored utilizing computer simulations. An in silico methodology for prodrug design based on the COSMOperm approach has been proposed and applied to four APIs (abiraterone, cytarabine, 5-fluorouracil, and paliperidone). It is shown that the addition of aliphatic hydrocarbon chains via ester or amide bonds can render the molecule more lipophilic and increase its permeability by approximately 1 order of magnitude for each 2 carbon atoms added, while the formation of fructose adducts can provide a more hydrophilic character to the molecule and reduce its lipid partitioning. While partitioning was found to depend only on the size and type of the added group, permeability was found to depend also on the added group location. Overall, it has been shown that both permeability and lipid partitioning coefficient can be systematically shifted into the desired liposome formulability window by appropriate group contributions to the parental drug. This can significantly increase the portfolio of APIs for which liposome or lipid nanoparticle formulations become feasible." @default.
• W4327894164 created "2023-03-21" @default.
• W4327894164 creator A5024587612 @default.
• W4327894164 creator A5027004289 @default.
• W4327894164 creator A5029994373 @default.
• W4327894164 creator A5049457524 @default.
• W4327894164 date "2023-03-20" @default.
• W4327894164 modified "2023-10-18" @default.
• W4327894164 title "Computational Prodrug Design Methodology for Liposome Formulability Enhancement of Small-Molecule APIs" @default.
• W4327894164 cites W1966078827 @default.
• W4327894164 cites W1971212169 @default.
• W4327894164 cites W1973866150 @default.
• W4327894164 cites W1977486075 @default.
• W4327894164 cites W1982297030 @default.
• W4327894164 cites W1989230986 @default.
• W4327894164 cites W2024726841 @default.
• W4327894164 cites W2041376702 @default.
• W4327894164 cites W2046963479 @default.
• W4327894164 cites W2048599811 @default.
• W4327894164 cites W2053688397 @default.
• W4327894164 cites W2063203176 @default.
• W4327894164 cites W2089545684 @default.
• W4327894164 cites W2102250394 @default.
• W4327894164 cites W2133641393 @default.
• W4327894164 cites W2154756937 @default.
• W4327894164 cites W2163581070 @default.
• W4327894164 cites W2168108459 @default.
• W4327894164 cites W2326404322 @default.
• W4327894164 cites W2431971411 @default.
• W4327894164 cites W2433570839 @default.
• W4327894164 cites W2772520223 @default.
• W4327894164 cites W2777235740 @default.
• W4327894164 cites W2798040410 @default.
• W4327894164 cites W2896212688 @default.
• W4327894164 cites W2911845838 @default.
• W4327894164 cites W2921669635 @default.
• W4327894164 cites W2954428948 @default.
• W4327894164 cites W2995145725 @default.
• W4327894164 cites W3014064183 @default.
• W4327894164 cites W3015889007 @default.
• W4327894164 cites W3037359618 @default.
• W4327894164 cites W3043722389 @default.
• W4327894164 cites W3048620154 @default.
• W4327894164 cites W3123328252 @default.
• W4327894164 cites W3127786658 @default.
• W4327894164 cites W4205691970 @default.
• W4327894164 cites W4220851750 @default.
• W4327894164 cites W4297106240 @default.
• W4327894164 doi "https://doi.org/10.1021/acs.molpharmaceut.2c01078" @default.
• W4327894164 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36939094" @default.
• W4327894164 hasPublicationYear "2023" @default.
• W4327894164 type Work @default.
• W4327894164 citedByCount "3" @default.
• W4327894164 countsByYear W43278941642023 @default.
• W4327894164 crossrefType "journal-article" @default.
• W4327894164 hasAuthorship W4327894164A5024587612 @default.
• W4327894164 hasAuthorship W4327894164A5027004289 @default.
• W4327894164 hasAuthorship W4327894164A5029994373 @default.
• W4327894164 hasAuthorship W4327894164A5049457524 @default.
• W4327894164 hasBestOaLocation W43278941641 @default.
• W4327894164 hasConcept C108215921 @default.
• W4327894164 hasConcept C178790620 @default.
• W4327894164 hasConcept C185154212 @default.
• W4327894164 hasConcept C185592680 @default.
• W4327894164 hasConcept C192157962 @default.
• W4327894164 hasConcept C21951064 @default.
• W4327894164 hasConcept C39944091 @default.
• W4327894164 hasConcept C41625074 @default.
• W4327894164 hasConcept C43617362 @default.
• W4327894164 hasConcept C50670333 @default.
• W4327894164 hasConcept C55493867 @default.
• W4327894164 hasConceptScore W4327894164C108215921 @default.
• W4327894164 hasConceptScore W4327894164C178790620 @default.
• W4327894164 hasConceptScore W4327894164C185154212 @default.
• W4327894164 hasConceptScore W4327894164C185592680 @default.
• W4327894164 hasConceptScore W4327894164C192157962 @default.
• W4327894164 hasConceptScore W4327894164C21951064 @default.
• W4327894164 hasConceptScore W4327894164C39944091 @default.
• W4327894164 hasConceptScore W4327894164C41625074 @default.
• W4327894164 hasConceptScore W4327894164C43617362 @default.
• W4327894164 hasConceptScore W4327894164C50670333 @default.
• W4327894164 hasConceptScore W4327894164C55493867 @default.
• W4327894164 hasFunder F4320321006 @default.
• W4327894164 hasFunder F4320324127 @default.
• W4327894164 hasIssue "4" @default.
• W4327894164 hasLocation W43278941641 @default.
• W4327894164 hasLocation W43278941642 @default.
• W4327894164 hasLocation W43278941643 @default.
• W4327894164 hasOpenAccess W4327894164 @default.
• W4327894164 hasPrimaryLocation W43278941641 @default.
• W4327894164 hasRelatedWork W2004998570 @default.
• W4327894164 hasRelatedWork W2026073350 @default.
• W4327894164 hasRelatedWork W2133602046 @default.
• W4327894164 hasRelatedWork W2133772902 @default.
• W4327894164 hasRelatedWork W2594002376 @default.
• W4327894164 hasRelatedWork W2916814365 @default.
• W4327894164 hasRelatedWork W3121764343 @default.
• W4327894164 hasRelatedWork W4286433606 @default.

• next